Anika Therapeutics
-
Extremities
Arthrosurface Returns to it Roots Following Divestiture from Anika Therapeutics
WEST BRIDGEWATER, Mass., Oct. 31, 2024 /PRNewswire/ — Executive management from Primo Medical Group along with others, combined to acquire Arthrosurface, Inc.,…
Read More » -
Sports Medicine
Anika Highlights Its Recently Launched Integrity™ Implant System and RevoMotion™ Reverse Shoulder Arthroplasty System Along with Other Key Regenerative Products During the 2024 AAOS Annual Meeting
Announcing the limited market release of X-Twist™ Fixation System with biocomposite suture anchor for rotator cuff and other soft tissue…
Read More » -
Recon
Anika Announces the Full Market Release of the RevoMotion™ Reverse Shoulder Arthroplasty System during the 2023 Orthopaedic Summit: Evolving Technologies (OSET) Annual Meeting
RevoMotion Reverse Shoulder Arthroplasty System significantly expands Anika’s shoulder arthroplasty portfolio and provides a bone conserving and innovative solution in…
Read More » -
Biologics
Anika Completes Enrollment in Hyalofast® U.S. Pivotal Phase III Study Achieving Key Milestone
Hyalofast – a single-stage, off-the-shelf, resorbable, hyaluronic acid scaffold for cartilage repair – is marketed in over 35 countries outside the U.S. where it…
Read More » -
Financial
Anika Enters Into Cooperation Agreement with Caligan Partners
Gary Fischetti Joins Anika Board Announces Share Repurchase Program Forms Capital Allocation Committee BEDFORD, Mass., April 13, 2023 (GLOBE NEWSWIRE)…
Read More » -
Extremities
Anika Continues to Expand Addressable Market for Tactoset® Injectable Bone Substitute with Additional 510(k) Clearance from FDA
Tactoset cleared by the FDA to be combined with autologous bone marrow aspirate, a core element for regenerative healing Anika…
Read More » -
Recon
Anika Announces First Surgeries Performed Using the New RevoMotion™ Reverse Shoulder Arthroplasty System and Commences Limited Market Release in the United States
RevoMotion significantly expands Anika’s shoulder arthroplasty portfolio and provides a new solution in the over $800 million U.S. reverse shoulder…
Read More » -
Extremities
Anika Receives FDA 510(k) Clearance for the X-Twist™ Knotless Fixation System, Expanding its Sports Medicine Soft Tissue Portfolio
X-Twist provides a simple, versatile knotless suture anchor system ideal for key repairs in the shoulder, foot and ankle, and…
Read More » -
Extremities
Anika Launches the WristMotion® Total Wrist Arthroplasty System at the American Society for Surgery of the Hand Annual Meeting
Designed to preserve natural motion and maximize stability, the WristMotion® Total Wrist Arthroplasty System provides an advanced solution for wrist…
Read More » -
Extremities
First Anika WristMotion® Total Wrist Arthroplasty Surgery Performed
WristMotion Total Wrist Arthroplasty limited launch initiated July 1, 2021 / Source: Anika Therapeutics Inc. BEDFORD, Mass., July 01, 2021 (GLOBE…
Read More » -
Financial
Anika Reports First Quarter 2021 Financial Results
Revenue lower by 3% versus pre-COVID in prior yearJoint Preservation revenue up 55% as transformative mix shift continuesCompany on track…
Read More » -
Extremities
Anika Announces FDA 510(k) Clearance for its WristMotion® Total Arthroplasty System for the Replacement of Painful Wrist Joints
BEDFORD, Mass., Oct. 21, 2020 (GLOBE NEWSWIRE) — Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company that creates and delivers…
Read More » -
Financial
Anika Appoints Michael Levitz as Chief Financial Officer
BEDFORD, Mass., Aug. 05, 2020 (GLOBE NEWSWIRE) — Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation, restoration and regenerative solutions…
Read More » -
Extremities
Anika To Launch Six FDA-Cleared Sports Medicine and Extremities Products in Third Quarter of 2020
BEDFORD, Mass., July 20, 2020 (GLOBE NEWSWIRE) — Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation, restoration and regenerative solutions…
Read More » -
Biologics
Anika Announces Planned CFO Transition
BEDFORD, Mass., June 02, 2020 (GLOBE NEWSWIRE) — Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company…
Read More »